Local and systemic innate immune response to secondary human peritonitis. Influence of micro-organism
暂无分享,去创建一个
J. Launay | E. Gayat | B. Cholley | D. Payen | F. Riché | P. Valleur | C. Collet | J. Mateo | M. Laisné
[1] J. Launay,et al. Local and systemic innate immune response to secondary human peritonitis , 2013, Critical Care.
[2] H. Friess,et al. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. , 2012, Immunobiology.
[3] F. Venet,et al. mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance , 2011, Critical care.
[4] Raquel Almansa,et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. , 2011, European cytokine network.
[5] Anastasia Antonopoulou,et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection , 2010, Critical care.
[6] C. Coopersmith,et al. Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses , 2010, Critical Care Medicine.
[7] A. Novotny. Biomarkers in SIRS and sepsis: Quo vadis? , 2010, Journal of emergencies, trauma, and shock.
[8] R. Pirracchio,et al. Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.
[9] B. Cholley,et al. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis , 2009, Critical care.
[10] Stephen J. Huang,et al. Gene-expression profiling of Gram-positive and Gram-negative sepsis in critically ill patients* , 2008, Critical care medicine.
[11] M. Singer,et al. Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery , 2007 .
[12] Javed Siddiqui,et al. Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality1 , 2006, The Journal of Immunology.
[13] C. Hennequin,et al. Candida as a risk factor for mortality in peritonitis* , 2006, Critical care medicine.
[14] Haichao Wang,et al. INTERFERON-γ INHIBITION ATTENUATES LETHALITY AFTER CECAL LIGATION AND PUNCTURE IN RATS: IMPLICATION OF HIGH MOBILITY GROUP BOX-1 , 2005, Shock.
[15] A. Mebazaa,et al. HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN-D RELATED EXPRESSION IS SPECIFICALLY ALTERED AND PREDICTS MORTALITY IN SEPTIC SHOCK BUT NOT IN OTHER CAUSES OF SHOCK , 2004, Shock.
[16] J. Mantz,et al. Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis , 2002, Intensive Care Medicine.
[17] H. Tsujimoto,et al. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. , 2001, American journal of surgery.
[18] J. Pugin,et al. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.
[19] W. Kox,et al. The value of immune modulating parameters in predicting the progression from peritonitis to septic shock. , 2001, Shock.
[20] C. Ebener,et al. Microbiology of postoperative peritonitis , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] B. Cholley,et al. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis , 2000, Critical care medicine.
[22] J. Siewert,et al. Essential Role of Gamma Interferon in Survival of Colon Ascendens Stent Peritonitis, a Novel Murine Model of Abdominal Sepsis , 1998, Infection and Immunity.
[23] J. Mohler,et al. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats , 1997, Infection and immunity.
[24] K. Asadullah,et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.
[25] M. Schein,et al. Hypothesis: compartmentalization of cytokines in intraabdominal infection. , 1996, Surgery.
[26] M. Schein,et al. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. , 1995, Archives of surgery.
[27] T. van der Poll,et al. Endogenous IL-10 protects mice from death during septic peritonitis. , 1995, Journal of immunology.
[28] K. Deen,et al. Interleukin 6 is a prognostic indicator of outcome in severe intra‐abdominal sepsis , 1994, The British journal of surgery.
[29] Claude Carbón,et al. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. , 1994, The Journal of infectious diseases.
[30] K. Tsukada,et al. Concentrations of cytokines in peritoneal fluid after abdominal surgery. , 1993, The European journal of surgery = Acta chirurgica.
[31] D. Leroy,et al. IFN-gamma involvement in the severity of gram-negative infections in mice. , 1993, Journal of immunology.
[32] P Franchimont,et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.
[33] S. Hofbauer,et al. Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. , 1992, Scandinavian journal of infectious diseases.
[34] J. Bartlett,et al. Microbial synergy in experimental intra-abdominal abscess , 1976, Infection and immunity.
[35] J. Bartlett,et al. Experimental Intra-Abdominal Abscesses in Rats: Quantitative Bacteriology of Infected Animals , 1974, Infection and immunity.